Free water imaging in Parkinson’s disease and atypical parkinsonian disorders
- 24 January 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (5) , 2521-2528
Abstract
Background Free water (FW)-corrected diffusion measures are more precise compared to standard diffusion measures. This study comprehensively evaluates FW and corrected diffusion metrics for whole brain white and deep gray matter (WM, GM) structures in patients with Parkinson’s disease (PD), progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) and attempts to ascertain the probable patterns of WM abnormalities. Method Diffusion MRI was acquired for subjects with PD (n = 133), MSA (n = 25), PSP (n = 30) and matched healthy controls (HC) (n = 99, n = 24, n = 12). Diffusion metrics of FA, MD, AD, RD were generated and FW, corrected FA maps were calculated using a bi-tensor model. TBSS was carried out at 5000 permutations with significance at p < 0.05. For GM, diffusivity maps were extracted from the basal ganglia, and analyzed at an FDR with p < 0.05. Results Compared to HC, PD showed focal changes in FW. MSA showed changes in the cerebellum and brainstem, and PSP showed increase in FW involving supratentorial WM and midbrain. All three showed increased substantia nigra FW. MSA, PSP demonstrated increased FW in bilateral putamen. PD showed increased FW in left GP externa, and bilateral thalamus. Compared to HC, MSA had increased FW in bilateral GP interna, and left thalamic. PSP had an additional increase in FW of the right GP externa, right GP interna, and bilateral thalamus. Conclusion The present study demonstrated definitive differences in the patterns of FW alterations between PD and atypical parkinsonian disorders suggesting the possibility of whole brain FW maps being used as markers for diagnosis of these disorders.Keywords
Funding Information
- Indian Council of Medical Research (ICMR/003/304/2013/00694)
- Department of Biotechnology, Ministry of Science and Technology, India (BT/ PR14315/MED/30/474/2010)
This publication has 45 references indexed in Scilit:
- Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairmentBrain, Behavior, and Immunity, 2013
- Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysisNeuroImage: Clinical, 2013
- How and how not to correct for CSF-contamination in diffusion MRINeuroImage, 2012
- Cytokine expression and microglial activation in progressive supranuclear palsyParkinsonism & Related Disorders, 2011
- The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's DiseasePsychosomatics, 2010
- Free water elimination and mapping from diffusion MRIMagnetic Resonance in Medicine, 2009
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 1996
- Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's diseaseNeuroscience Letters, 1996
- Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsNeuroscience Letters, 1995